Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer02:18

Cancer

53.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

3.1K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription.

Research square·2026
Same author

Identification of the cellular transcription factor KLF16 as a novel repressive epigenetic repressor of HIV-1 transcription.

bioRxiv : the preprint server for biology·2026
Same author

Organobodies: a robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screening.

Biofabrication·2026
Same author

Effects of NAD⁺ repletion with Nicotinamide riboside on obesity-induced chronic kidney disease and renal cell lipotoxicity.

Scientific reports·2026
Same author

PARP inhibitors induce a senescence phenotype in non-small cell lung carcinoma cell lines.

FEBS open bio·2026
Same author

Primary Alveolar Echinococcosis of the Kidney.

Revista da Sociedade Brasileira de Medicina Tropical·2026

Related Experiment Video

Updated: Dec 26, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.9K

MPV17 does not control cancer cell proliferation.

Morgane Canonne1, Anaïs Wanet1, Thuy Truong An Nguyen1

  • 1Laboratory of Biochemistry and Cell Biology (URBC), NAmur Research Institute for LIfe Sciences (NARILIS), University of Namur (UNamur), Namur, Belgium.

Plos One
|March 11, 2020
PubMed
Summary

MPV17 (mitochondrial inner membrane channel protein) does not affect mitochondrial DNA content or cancer cell proliferation. Rescue experiments are crucial to validate gene silencing results, preventing misinterpretations in cancer research.

More Related Videos

Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
12:35

Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines

Published on: September 3, 2016

20.0K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.4K

Related Experiment Videos

Last Updated: Dec 26, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.9K
Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
12:35

Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines

Published on: September 3, 2016

20.0K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.4K

Area of Science:

  • Mitochondrial biology
  • Cancer cell biology
  • Molecular genetics

Background:

  • MPV17 is a mitochondrial inner membrane channel protein.
  • Mutations in MPV17 cause hepato-cerebral mitochondrial DNA depletion syndrome.
  • The precise function of MPV17 in cellular processes, including cancer, is not fully understood.

Purpose of the Study:

  • To investigate the role of MPV17 in cancer cells.
  • To determine if MPV17 silencing affects mitochondrial DNA content.
  • To clarify the impact of MPV17 on cancer cell proliferation.

Main Methods:

  • MPV17 gene silencing using shRNA in cancer cell lines.
  • Assessment of mitochondrial DNA content.
  • Evaluation of cancer cell proliferation rates.
  • Rescue experiments to validate gene silencing effects.

Main Results:

  • MPV17 silencing did not lead to mitochondrial DNA depletion in cancer cells.
  • Initial observations of reduced proliferation after MPV17 silencing were misleading.
  • Rescue experiments confirmed that MPV17 does not control cancer cell proliferation.

Conclusions:

  • Caution is required when interpreting results from lentiviral vector-based gene silencing.
  • Rescue experiments are essential to confirm the specific effects of gene silencing and avoid misinterpretations in cancer research.